Xlife Sciences AG (XLS) | WebDisclosure

Basculer en Français

11145	Companies
245638	Keywords
173702	Articles
132576	Press releases

Home
Companies
Xlife Sciences AG

PRESS RELEASE

published on 11/28/2025 at 13:10, 10 months 9 days ago

Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown
Xlife Sciences AG updates on VERAXA Biotech AG's NASDAQ listing process post U.S. Government Shutdown, SEC responds to Form F-4 filing, progress towards business combination with Voyager Acquisition Corp

Nasdaq SEC Xlife Sciences AG VERAXA Biotech AG Voyager Acquisition Corp.
BRIEF

published on 10/16/2025 at 07:05, 11 months 22 days ago

Xlife Sciences AG publie son rapport ESG 2024 mettant en avant la croissance durable

Croissance Durable Responsabilité Sociale Impact Environnemental Xlife Sciences Rapport ESG 2024
BRIEF

published on 10/16/2025 at 07:05, 11 months 22 days ago

Xlife Sciences AG Releases 2024 ESG Report Highlighting Sustainable Growth

Environmental Impact Social Responsibility Sustainable Growth Xlife Sciences ESG Report 2024
PRESS RELEASE

published on 10/16/2025 at 07:00, 11 months 22 days ago

Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a Strategic Core
Xlife Sciences AG publishes 2024 ESG Report showcasing sustainable value creation through integrating ESG principles into corporate strategy and portfolio management in life sciences sector

Life Sciences Xlife Sciences AG ESG Principles Sustainable Value Creation 2024 ESG Report
BRIEF

published on 09/23/2025 at 07:05, 1 year ago

Xlife Sciences AG Focuses on VERAXA's NASDAQ Listing in H1 2025

Financial Performance Nasdaq Listing Global Partnerships Xlife Sciences Biotech Expansion
BRIEF

published on 09/23/2025 at 07:05, 1 year ago

Xlife Sciences AG se concentre sur l'introduction de VERAXA au NASDAQ au premier semestre 2025

Performance Financière Partenariats Mondiaux Xlife Sciences Cotation Au Nasdaq Expansion Biotechnologique
PRESS RELEASE

published on 09/23/2025 at 07:00, 1 year ago

Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Listing and Internationalization
Xlife Sciences AG released its Half-Year Report 2025 with focus on VERAXA Biotech AG's NASDAQ listing and internationalization. Operational and financial highlights were shared along with clear priorities for H2 2025

Nasdaq Listing Xlife Sciences AG Internationalization VERAXA Biotech AG Half-Year Report 2025
BRIEF

published on 07/17/2025 at 07:05, 1 year 2 months ago

VERAXA Biotech AG progresse vers la cotation au NASDAQ grâce au dépôt du formulaire F-4

Cotation Au Nasdaq VERAXA Biotech Regroupement D'entreprises Dépôt Du Formulaire F-4 Thérapeutiques Oncologiques
BRIEF

published on 07/17/2025 at 07:05, 1 year 2 months ago

VERAXA Biotech AG Advances Toward NASDAQ Listing with Form F-4 Filing

Nasdaq Listing Business Combination Oncology Therapeutics VERAXA Biotech Form F-4 Filing
PRESS RELEASE

published on 07/17/2025 at 07:00, 1 year 2 months ago

Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4
Xlife Sciences AG's portfolio company VERAXA Biotech AG takes a key step towards NASDAQ listing with the filing of Form F-4, signaling continued momentum and billion-dollar valuation in the public market journey

Nasdaq Listing Business Combination Xlife Sciences AG VERAXA Biotech AG Form F-4

Accesswire

Published on 10/07/2026 at 23:30, 4 hours 32 minutes ago

Algo Grande Copper Core Testing Shows Mineralized Skarn is Denser and More Chargeable Than Host Rocks; Ground Gravity Survey to Begin at Adelita
Published on 10/07/2026 at 22:05, 5 hours 57 minutes ago

Loar Holdings Inc. Announces Date and Time for Third Quarter 2026 Earnings and Conference Call
Published on 10/07/2026 at 17:00, 11 hours 2 minutes ago

BlackBerry Radar Expands Asset Intelligence Platform with Dynamic Pairing
Published on 10/07/2026 at 15:30, 12 hours 32 minutes ago

Gold Port Announces Marketing Agreement with NAI Interactive Ltd.
Published on 10/07/2026 at 14:30, 13 hours 32 minutes ago

Secure Blockchain's Agentic Solutions Signs Financial Services Firm, Expanding Enterprise AI Into Corporate Finance

View all ACCESSWIRE

EQS Group

Published on 10/07/2026 at 23:30, 4 hours 32 minutes ago

Acuity Analytics expands US data and technology capabilities with acquisition of Continuus
Published on 10/07/2026 at 23:20, 4 hours 42 minutes ago

BAR LEONE, HONG KONG, IS THE WORLD'S BEST BAR AS THE LIST OF THE 50 BEST BARS 2026 IS REVEALED
Published on 10/07/2026 at 22:00, 6 hours 2 minutes ago

Invitation - Q3 2026 Trading Update Conference Call
Published on 10/07/2026 at 21:35, 6 hours 27 minutes ago

OCI N.V. Notes Enterprise Chamber Decision Not to Order Inquiry
Published on 10/07/2026 at 20:55, 7 hours 6 minutes ago

innoscripta SE Initiates Independent External Investigations to Clarify the Facts Underlying the Authorities’ Investigations and Review Clusterix’s Documentation and Control Mechanisms

Les Echos

Published on 10/07/2026 at 20:15, 7 hours 46 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 10/07/2026 at 20:15, 7 hours 47 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 10/07/2026 at 20:15, 7 hours 47 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES SEPTEMBRE 2026
Published on 10/07/2026 at 20:15, 7 hours 47 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES SEPTEMBRE 2026
Published on 10/07/2026 at 18:19, 9 hours 42 minutes ago

Outstanding shares and voting rights statement at 30 September 2026

View all LES ECHOS COMFI WIRE